@return2ozma to News • 8 months ago'Positive Step,' Says Sanders After AstraZeneca Agrees to Cap Inhalers at $35www.commondreams.orgexternal-linkmessage-square26arrow-up1568arrow-down18
arrow-up1560arrow-down1external-link'Positive Step,' Says Sanders After AstraZeneca Agrees to Cap Inhalers at $35www.commondreams.org@return2ozma to News • 8 months agomessage-square26
minus-squareFlying Squidlink5•8 months agoThey would still be profitable at $5 most likely. They always argue that the added cost covers the R&D.
They would still be profitable at $5 most likely.
They always argue that the added cost covers the R&D.